【精优药业(00858.HK)发盈喜 预期年度业绩同比扭亏为盈至约2.15亿港元-2.25亿港元】智通财经APP讯,精优药业(00858.HK)公布,该集团预期截至2025年3月31日止年度取得溢利约2.15亿港元-2.25亿港元,同比扭亏为盈。转亏为盈主要由于非现金项目,因按公平值计入损益的金融资产(
即集团可换股债券投资 )的公平值变动产生的收益所致,而去年相应期间同一非现金项目则取得公平值变动的亏损。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.